Can I read Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis on EtoBox?

Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis by Xiaopeng Huang; Siyun Li; Wenjie Lu; Longjiang Xiong is a Medicine article available to read on EtoBox.

What is Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis about?

## Abstract ## Background With the deepening of social aging, the incidence rate of osteoporosis and diabetes continues to rise. More and more clinical studies show that diabetes is highly correlated with osteoporosis. Diabetes osteoporosis is considered as a metabolic bone disease of diabetes patients. This study aims to explore the role and mechanism of metformin (Met) in diabetic osteoporosis. ## Methods Mouse MC3T3-E1 cells were treated with Met (0.5 mM) and exposed to high glucose (HG, 35 mM). The cells were cultured in an osteogenic medium for osteogenic differentiation, and the cell proliferation ability was determined using Cell Counting Kit-8; Alkaline phosphatase (ALP) activity detection and alizarin red staining were utilized to evaluate the effect of Met on MC3T3-E1 osteogenic differentiation. Western blot was used to detect the expressions of osteogenesis-related proteins (Runx2 and OCN) as well as Wnt/β-catenin signaling pathway-related proteins in MC3T3-E1 cells. ## Results HG inhibited proliferation and calcification of MC3T3-E1 cells, down-regulated ALP activity, and the expression of Runx2 and OCN in MC3T3-E1 cells. Meanwhile, the activity of the Wnt/β-catenin sig

Who reads Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis?

Author

Xiaopeng Huang; Siyun Li; Wenjie Lu; Longjiang Xiong

Publisher

Springer Science and Business Media LLC

Published

2022

Language

EN

Field

Medicine (Health Sciences)